Cargando…

Cytotoxic Action of Carboxyborane Heterocyclic Amine Adducts

The heterocyclic carboxyborane amines were found to be potent cytotoxic agents in the murine L1210 lymphoid leukemia and human HeLa suspended carcinoma cells. These agents were observed to inhibit HeLa DNA topoisomerase II activity ~ 200 μM and L1210 topoisomerase II activity ≥ 100 μM. These agents...

Descripción completa

Detalles Bibliográficos
Autores principales: Miller, Merrill C., Sood, Anup, Spielvogel, Bernard F., Bastow, Ken, Hall, Iris H.
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365064/
https://www.ncbi.nlm.nih.gov/pubmed/18475792
http://dx.doi.org/10.1155/MBD.1997.229
_version_ 1782154077230071808
author Miller, Merrill C.
Sood, Anup
Spielvogel, Bernard F.
Bastow, Ken
Hall, Iris H.
author_facet Miller, Merrill C.
Sood, Anup
Spielvogel, Bernard F.
Bastow, Ken
Hall, Iris H.
author_sort Miller, Merrill C.
collection PubMed
description The heterocyclic carboxyborane amines were found to be potent cytotoxic agents in the murine L1210 lymphoid leukemia and human HeLa suspended carcinoma cells. These agents were observed to inhibit HeLa DNA topoisomerase II activity ~ 200 μM and L1210 topoisomerase II activity ≥ 100 μM. These agents did not cause DNA protein linked breaks themselves, but upon incubation for 14-24 hr did enhance the ability of VP-16 to cause cleavable complexes. The heterocyclic amineboranes inhibited DNA synthesis and caused DNA strand scission. They were additive with VP-16 in affording these results as well as inhibiting colony growth of L1210 cells after co-incubation for 1 hr. The agents inhibited in vitro PKC phosphorylation of both L1210 lymphoid leukemia and human topoisomerase II enzyme.
format Text
id pubmed-2365064
institution National Center for Biotechnology Information
language English
publishDate 1997
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-23650642008-05-12 Cytotoxic Action of Carboxyborane Heterocyclic Amine Adducts Miller, Merrill C. Sood, Anup Spielvogel, Bernard F. Bastow, Ken Hall, Iris H. Met Based Drugs Research Article The heterocyclic carboxyborane amines were found to be potent cytotoxic agents in the murine L1210 lymphoid leukemia and human HeLa suspended carcinoma cells. These agents were observed to inhibit HeLa DNA topoisomerase II activity ~ 200 μM and L1210 topoisomerase II activity ≥ 100 μM. These agents did not cause DNA protein linked breaks themselves, but upon incubation for 14-24 hr did enhance the ability of VP-16 to cause cleavable complexes. The heterocyclic amineboranes inhibited DNA synthesis and caused DNA strand scission. They were additive with VP-16 in affording these results as well as inhibiting colony growth of L1210 cells after co-incubation for 1 hr. The agents inhibited in vitro PKC phosphorylation of both L1210 lymphoid leukemia and human topoisomerase II enzyme. Hindawi Publishing Corporation 1997 /pmc/articles/PMC2365064/ /pubmed/18475792 http://dx.doi.org/10.1155/MBD.1997.229 Text en Copyright © 1997 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Miller, Merrill C.
Sood, Anup
Spielvogel, Bernard F.
Bastow, Ken
Hall, Iris H.
Cytotoxic Action of Carboxyborane Heterocyclic Amine Adducts
title Cytotoxic Action of Carboxyborane Heterocyclic Amine Adducts
title_full Cytotoxic Action of Carboxyborane Heterocyclic Amine Adducts
title_fullStr Cytotoxic Action of Carboxyborane Heterocyclic Amine Adducts
title_full_unstemmed Cytotoxic Action of Carboxyborane Heterocyclic Amine Adducts
title_short Cytotoxic Action of Carboxyborane Heterocyclic Amine Adducts
title_sort cytotoxic action of carboxyborane heterocyclic amine adducts
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2365064/
https://www.ncbi.nlm.nih.gov/pubmed/18475792
http://dx.doi.org/10.1155/MBD.1997.229
work_keys_str_mv AT millermerrillc cytotoxicactionofcarboxyboraneheterocyclicamineadducts
AT soodanup cytotoxicactionofcarboxyboraneheterocyclicamineadducts
AT spielvogelbernardf cytotoxicactionofcarboxyboraneheterocyclicamineadducts
AT bastowken cytotoxicactionofcarboxyboraneheterocyclicamineadducts
AT hallirish cytotoxicactionofcarboxyboraneheterocyclicamineadducts